MedTrace Logo

National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

NCT07305961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1332

Last updated 2026-03-27

No results posted yet for this study

Summary

Multicentre retrospective, prospective, non-profit, national observational study

Conditions

  • Scabies

Interventions

OTHER

data collection

Biographical data: age; immunodeficiency; bedridden condition. Household data: number of people in the household, original state of the household, presence of paediatric cases weighing more or less than 15 kg, presence of a language barrier. Diagnostic criteria: clinical, dermatoscopic and/or microscopic. Clinical data: affected areas, non-specific therapies previously carried out. Days of isolation of the index case (if applicable). Treatment data: the first specific anti-mite therapy carried out, including the mode of administration; the number of days since the onset of the illness; the number of people treated per index case; the drug with which recovery was achieved (if known); and the time taken for recovery. Data for investigating treatment failures: answers to questions concerning treatment carried out with close contacts and cohabitants, correct information about environmental remediation implementation, number of therapy cycles carried out and follow-up timeframe.

OTHER

data collection

Only the number of registered scabies cases and whether or not treatment has failed will be taken into account. No clinical data from the patients will be extrapolated.

Sponsors & Collaborators

  • Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07305961 on ClinicalTrials.gov